Identification of a bacterial inhibitor of G-type lysozyme
Vanderkelen, L.; Callewaert, L.; Van Herreweghe, J.; Aertsen, A.; Michiels, C.W.
Communications in Agricultural and Applied Biological Sciences 73(1): 227-230
2008
ISSN/ISBN: 1379-1176 PMID: 18831280 Document Number: 619296
Document emailed within 1 workday
Related Documents
Cava, L.; Pozzoli, R.; Chiodo, F. 1975: Evaluation of the lysozyme and DNAase activity for the identification of pathogenic staphylococci Bollettino dell'Istituto Sieroterapico Milanese 54(4): 300-304Gerstein, E.S.; Shcherbakov, A.M.; Kaz'min, A.I.; Ognerubov, N.A.; Kushlinskiĭ, N.E. 2003: Urokinase and tissue type plasminogen activators and their type-1 inhibitor (PAI-1) in gastric cancer Voprosy Onkologii 49(2): 165-169
Zidek, W. 2004: Diabetes and Nephropathy: ACE inhibitor for type 1, AT1 blocker for type 2 MMW Fortschritte der Medizin 146(42): 51-52
Hashimoto, S.; Kira, A.; Imamura, M.; Masuda, T. 1982: Lysozyme dimer formation on lysozyme oxidation with Br2 radical as studied by fluorescence evolution International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine 41(3): 303-314
Perunova, N.B.; Andriushchenko, S.V.; Bukharin, O.V. 2012: Genetic determinants of secreted lysozyme inhibitors and enterobacteria anti-lysozyme phenotype Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 6: 8-12
Satot, T.; Kawamoto, E.; Yamada, J. 2009: Identification and classification of lysozyme-expressing cells in the mouse small intestinal crypt and their correlation with the morphology of secretory granules and labeling density of immunogold Kaibogaku Zasshi. Journal of Anatomy 84(3): 83-91
Babaian, S.S.; Pokidova, N.V.; Ermol'eva, Z.V. 1974: The effect of human lysozyme and egg lysozyme on tissue cultures Antibiotiki 19(1): 83-86
Ricci, A.J.; Rennie, K.J.; Cochran, S.L.; Kevetter, G.A.; Correia, M.J. 1997: Vestibular type i and type Ii hair cells. 1: Morphometric identification in the pigeon and gerbil Journal of Vestibular Research: Equilibrium and Orientation 7(5): 393-406
Ke, C.; Bai, Q.; Geng, X. 2004: Design and resolution of a simple-type column for renaturation with simultaneous purification of proteins and its application to lysozyme refolding Se Pu 22(4): 394-398
Gastaldi, G.; Mattiello, A. 1971: Effect of a protease inhibitor on bacterial multiplication Pathologica 63(923): 223-231
Zaki, Z.; Shoukry, S.; Abdallah, N.M. 1979: Syriamycin, a new inhibitor for protein synthesis in bacterial and tumour cells Indian Journal of Experimental Biology 17(8): 721-723
Kratasiuk, G.A.; Kratasiuk, V.A.; Shenderov, A.N.; Fish, A.M. 1978: Isolation of bacterial luminescence reaction inhibitor from Photobacterium sp. cells Biokhimiia 43(8): 1369-1376
Jin, H.J.; Oh, M.Y.; Jin, D.H.; Hong, Y.K. 2008: Identification of a Taq DNA polymerase inhibitor from the red seaweed Symphyocladia latiuscula Journal of Environmental Biology 29(4): 475-478
Stetler-Stevenson, W.G.; Krutzsch, H.C.; Liotta, L.A. 1992: TIMP-2: identification and characterization of a new member of the metalloproteinase inhibitor family Matrix . Supplement 1: 299-306
Stevens, M. 1980: Computer assisted bacterial identification Medical Laboratory Sciences 37(3): 223-228
Foulongne, V.; Michaux-Charachon, S.; Jumas-Bilak, E.; O'Callaghan, D.; Ramuz, M. 2004: Strategies for bacterial virulence genes identification Pathologie-Biologie 52(2): 104-114
Avni, I.; Arffa, R.C.; Robin, J.B.; Rao, N.A. 1987: Lectins for the identification of ocular bacterial pathogens Metabolic Pediatric and Systemic Ophthalmology 10(2): 45-47
Medina, J.H.; Novas, M.L.; De Robertis, E.; Pena, C.; Paladini, A.C. 1986: Identification of a potent endogenous benzodiazepine binding inhibitor from bovine cerebral cortex Advances in Biochemical Psychopharmacology 42: 47-56
Sprengers, E.D.; Akkerman, J.W.; Jansen, B.G. 1986: Blood platelet plasminogen activator inhibitor: two different pools of endothelial cell type plasminogen activator inhibitor in human blood Thrombosis and Haemostasis 55(3): 325-329
Harbeck, N.; Kates, R.E.; Look, M.P.; Meijer-Van Gelder, M.E.; Klijn, J.G.M.; Krüger, A.; Kiechle, M.; Jänicke, F.; Schmitt, M.; Foekens, J.A. 2002: Enhanced benefit from adjuvant chemotherapy in breast cancer patients classified high-risk according to urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (n = 3424) Cancer Research 62(16): 4617-4622